These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6836527)

  • 1. [Systemic arterial hypertension and lung disease].
    Mukharliamov NM
    Ter Arkh; 1983; 55(1):54-7. PubMed ID: 6836527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Respiration in patients with chronic lung diseases in association with systemic arterial hypertension].
    Koshlia VI
    Vrach Delo; 1983 Jan; (1):97-9. PubMed ID: 6868513
    [No Abstract]   [Full Text] [Related]  

  • 3. [A role of the endothelium in the development of pulmonary hypertension in patients with chronic obstructive lung diseases].
    Karoli NA; Rebrov AP
    Klin Med (Mosk); 2004; 82(8):8-14. PubMed ID: 15468716
    [No Abstract]   [Full Text] [Related]  

  • 4. Are pulmonary haemodynamics of importance to survival in chronic obstructive lung disease?
    Harris P
    Eur Respir J Suppl; 1989 Jul; 7():674s-677s. PubMed ID: 2679614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of renin-angiotensin system in pathogenesis of pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Frangulian RR
    Klin Med (Mosk); 2000; 78(10):18-20. PubMed ID: 11220892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-functional evaluation of chronic obstructive lung diseases in association with hypertension].
    Soldatchenko SS; Kononenko IN; Rudieva NB; P'iankov AF
    Vrach Delo; 1991 Jun; (6):42-3. PubMed ID: 1891848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic arterial hypertension in chronic bronchial obstruction: current views and new understandings].
    Bobrov VA; Fushteĭ IM; Bobrova VI
    Klin Med (Mosk); 1995; 73(3):24-8. PubMed ID: 8577100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamics of pulmonary circulation in patients with chronic obstructive lung disease and pulmonary hypertension as dependent on the theophylline concentration of the serum].
    Grützmacher I; Schicht R; Schlaeger R; Sill V
    Prax Klin Pneumol; 1984 Jan; 38(1):19-25. PubMed ID: 6709589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic arterial hypertension in chronic lung diseases].
    Kubyshkin VF; Soldatchenko SS
    Ter Arkh; 1982; 54(2):90-5. PubMed ID: 6918177
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary hypertension in chronic obstructive bronchopneumopathy (COBP): possible role of platelets].
    Carratù L; Pezza A; Sofia M; Mormile M
    Arch Monaldi Mal Torace; 1987; 42(1):81-92. PubMed ID: 3334003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and treatment of systemic arterial hypertension in chronic obstructive lung diseases].
    Kubyshkin VF; Soldatchenko SS
    Vrach Delo; 1983 Dec; (12):24-6. PubMed ID: 6670228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of pulmonary hypertension in chronic obstructive lung diseases].
    Mitre N; Kasinski N; Romaldini H
    Arq Bras Cardiol; 1987 Jan; 48(1):61-5. PubMed ID: 3662895
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution of pulmonary hypertension in chronic respiratory diseases.
    Weitzenblum E; Jezek V
    Bull Eur Physiopathol Respir; 1984; 20(1):73-81. PubMed ID: 6704569
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary hypertension in chronic obstructive lung disease. Hemodynamic changes induced by oxygen, verapamil, and isoproterenol acute administration (author's transl)].
    Sclavo M; Bucca C; Rolla G; Borello G; Balbi L; Angelino PF
    G Ital Cardiol; 1981; 11(5):634-42. PubMed ID: 7286534
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypoxic pulmonary hypertension: nifedipine therapy].
    Agostoni P; Doria E; Galli C; Tamborini G; Fiorentini C; Guazzi M
    Cardiologia; 1988 Oct; 33(10):961-9. PubMed ID: 3233606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathogenetic mechanisms and the the clinical aspects of secondary pulmonary hypertension and respiratory system diseases].
    Carratu' L; Marangio E; Cuomo A; Pesci A
    Torace; 1979 Mar; 22(1):50-71. PubMed ID: 400054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiohemodynamic pulmonary assessment in environmental respiratory disease].
    Iodice F; De Michele F
    Arch Monaldi Mal Torace; 1989; 44(4-6):991-9. PubMed ID: 2577821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinicofunctional features of arterial hypertension in chronic broncho-obstructive syndrome].
    Zadionchenko VS; Kuz'micheva NV; Sviridov AA; Ol'kha RP; Kashcheeva EV
    Ter Arkh; 2000; 72(1):51-5. PubMed ID: 10687208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of pulmonary hypertension in chronic obstructive pulmonary disease].
    Mitre N; Romaldini H; Kasinski N; Ferreira C; Paola AA; Martinez Filho EE
    Arq Bras Cardiol; 1988 Feb; 50(2):79-85. PubMed ID: 3214319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.